Fulltext
The full text of this article is available on PDF.
Journal of Health Reports and Technology
The Official Journal of Kermanshah University of Medical Sciences
e-ISSN 2783-2511
Image Credit:J Health Rep Technol
Outline
Is money thicker than health? - Economic motivated off-label prescription in an austere Europe
Authors
1Faculty of Law, Coimbra University, Portugal & Faculty of Law, Macau University, China
*Corresponding Author: Corresponding author: Vera Lúcia Raposo, Faculty of Law, Coimbra University, Portugal & Faculty of Law, Macau University, China Email: vera@fd.uc.pt
Published online:Jul 01, 2017
Article type:Review Article
Received:Jun 02, 2017
Accepted:Jun 15, 2017
How to Cite:Raposo VL. Is money thicker than health? - Economic motivated off-label prescription in an austere Europe. J Health Rep Technol. 2017;3(1):e74182. doi:
Abstract
Off-label prescription is common in Europe and economically motivated off-label prescription is being increasingly recognised by the national laws of the Member States of the European Union, even though both European law and the European courts refute the prevalence of financial considerations over public health.
This article examines the causes of economically motivated off-label prescription, the current legislative and administrative measures implemented in several European countries and its consequences, and it concludes that in very specific scenarios off-label prescription grounded in economic reasons should be allowed.
Highlights
References
- 1.The references of this article is available on PDF.
Copyright
© 2017, Journal of Health Reports and Technology. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
20
Nov
2010
The Need to Establish a Common Base Line for the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets
Jalal Pourahmad
Pourahmad J. The Need to Establish a Common Base Line for the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets. Iran J Pharm Res. 2022;7(4):e128597. doi: https://doi.org/10.22037/ijpr.2010.771
30
Apr
2015
Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods
abbas kebriaeezadeh
kebriaeezadeh A. Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods. Iran J Pharm Res. 2015;14(2):e125349. doi: https://doi.org/10.22037/ijpr.2015.1663
31
Jul
2014
“Budget Impact Analyses”: A Practical Policy Making Tool for Drug Reimbursement Decisions
Hamid Reza Jamshidi,
Naghmeh Foroutan,
Jamshid Salamzadeh
Jamshidi HR, Foroutan N, Salamzadeh J. “Budget Impact Analyses”: A Practical Policy Making Tool for Drug Reimbursement Decisions. Iran J Pharm Res. 2014;13(3):e125507. doi: https://doi.org/10.22037/ijpr.2014.1535
31
Jan
2021
Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran
Nikinaz Ashrafi Shahmirzadi,
Akbar Abdollahiasl,
Abbas Kebriaeezadeh
Ashrafi Shahmirzadi N, Abdollahiasl A, Kebriaeezadeh A. Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran. Iran J Pharm Res. 2021;20(1):e124361. doi: https://doi.org/10.22037/ijpr.2020.112288.13662
30
Sep
2020
Evaluation of Rights Related to Public Health and Pharmaceutical Patents and Existing Conflicts According to National and International Laws
Somayeh Rahmani,
Amir Mahdi Ghorbanpoor Zarehshuran,
Hamideh Rahanjam
Rahmani S, Ghorbanpoor Zarehshuran AM, Rahanjam H. Evaluation of Rights Related to Public Health and Pharmaceutical Patents and Existing Conflicts According to National and International Laws. J Inflamm Dis. 2024;24(3):e156221. doi:
Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 1
Last Update: 1 week ago
- CrossRef: 0
Last Update: 5 days ago
- OpenAlex: 0
Last Update: 1 hour ago
- OpenCitations: 0
Last Update: 3 days ago
Comments
Number of Comments:0